Nasus Pharma Ltd Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
Nasus Pharma Ltd (NSRX) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $10.00 per share as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2026-03-25
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $10.00.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $3.47.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2025-12-31 | $10.00 20-F · filed 2026-03-25 |
| 2024-12-31 | $3.47 20-F · filed 2026-03-25 |